Neuropathy in Parkinson’s Disease Patients with Intestinal Levodopa Infusion versus Oral Drugs

Open Access

Peer-reviewed

Research Article

Constanze Jugel,

Affiliation Department of Neurology, Charité - University Medicine, Campus Benjamin Franklin, Berlin, Germany
⨯
Felicitas Ehlen,

Affiliation Department of Neurology, Charité - University Medicine, Campus Benjamin Franklin, Berlin, Germany
⨯
Birol Taskin,

Affiliation Department of Neurology, Charité - University Medicine, Campus Benjamin Franklin, Berlin, Germany
⨯
Frank Marzinzik,

Affiliation Department of Neurology, Charité - University Medicine, Campus Benjamin Franklin, Berlin, Germany
⨯
Thomas Müller,

Affiliation Department of Neurology, St. Joseph-Hospital, Berlin-Weissensee, Germany
⨯
Fabian Klostermann

* E-mail: fabian.klostermann@charite.de

Affiliation Department of Neurology, Charité - University Medicine, Campus Benjamin Franklin, Berlin, Germany
⨯

Reader Comments (0)

Neuropathy
Is the Subject Area "Neuropathy" applicable to this article?

Thanks for your feedback.
Parkinson disease
Is the Subject Area "Parkinson disease" applicable to this article?

Thanks for your feedback.
Sensory perception
Is the Subject Area "Sensory perception" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Levodopa
Is the Subject Area "Levodopa" applicable to this article?

Thanks for your feedback.
Gastrointestinal tract
Is the Subject Area "Gastrointestinal tract" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.